1 January 2012PatentsArchana Shanker

A step into the unknown: India's first compulsory license

The licence was granted to Natco Pharma, a generic drug company, for sorafenib tosylate, a life-extending drug developed, patented and launched by Bayer Corporation. This drug is sold under the trade name of Nexavar and is used for the treatment of advanced-stage kidney and liver cancer.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Influential Women in IP

The real impact of judgments

1 December 2020 Justice Prabha Sridevan has left her mark on the Indian IP industry, first as a judge of the Madras High Court, and then as chair of the Intellectual Property Appellate Board. Here, she tells WIPR about two cases that she will always remember.

India e-commerce: Liability for platforms is coming at last

24 September 2019 India’s booming e-commerce industry has remained largely immune to the cries of rights owners, but not for much longer, explains Pravin Anand, Jaya Negi and Souradeep Mukhopadhyay.

UK-India trade deal is ‘missed opportunity’, say industry bodies

WATCH: Recent developments in design patent law

SEPs now searchable on WIPO’s global patent database

'Nothing can stand in the way of our work': Ukraine resumes IP system

WATCH: Finding a new balance in IP protection with trade secret protection

Optis v Apple: How the court calculated the royalty rate

Apple must pay Optis $700m-the biggest patent award in UK history

Wouter Pors leaves Bird & Bird for boutique Dutch firm

A step into the unknown: India's first compulsory license

More on this story

Editor's picks

Editor's picks

More articles